Ese twavuga kuri iyi kanseri ikomeye y'amaraso, kanseri y'amaraso ifata amaraso menshi (AML)?

Ese ufite ibicurane bidashira nyuma y'iminsi mike? Cyangwa wumva unaniwe kandi unaniwe? Hari igihe ibintu bito nk'ibi bishobora guhisha ikintu gikomeye. Uyu munsi tugiye kuvuga ku ndwara ikomeye gato, ariko ni ngombwa cyane kuyimenya. Iyo ni indwara ya kanseri y'imitsi ikabije, cyangwa AML mu magambo ahinnye.

AML ni iki?

Mu magambo make, kanseri ya Acute Myeloid Leukemia (AML) ni ubwoko bwa kanseri ifata umwongo w'amagufwa n'amaraso. Ni indwara idakunze kugaragara ariko ikomeye. Akenshi iterwa n'impinduka muri imwe muri gene cyangwa chromosomes. Ikunze kugaragara cyane ku bantu barengeje imyaka 60. Ariko, ishobora no kwibasira abakiri bato n'abana. AML ni kanseri ikwirakwira vuba kandi ishobora gushyira ubuzima mu kaga. Ku bw'amahirwe, uburyo bushya bwo kuvura bwatumye abantu benshi baramba iyo ndwara.

Ese hari ubwoko butandukanye bwa AML?

Yego, hari ubwoko butandukanye bwa AML. Buri bwoko muri ubu bugira ingaruka ku mubare w'uturemangingo mu maraso yawe. Ariko, buri bwoko bushobora gutera ibimenyetso bitandukanye kandi bugakira mu buryo butandukanye ku buvuzi.

Abaganga basuzuma utwo duce twa AML basuzuma uturemangingo twa kanseri bakoresheje mikorosikopi. Banashakisha impinduka muri chromosomes zawe n'impinduka mu turemangingo tumwe na tumwe tugenzura imikurire y'uturemangingo.

Dore zimwe mu nkomoko z'ingenzi za AML:

• Leukemia ya Myeloid: Iyi ni yo ndwara ikunze kugaragara cyane ya AML. Ikura nk'indwara ya kanseri y'uturemangingo dukora neutrophils, ubwoko bw'uturemangingo tw'amaraso twera.
• Leukemia ya monocytic ikabije (AML-M5): Iyi ndwara ikwirakwira mu turemangingo dukora ubwoko bw'uturemangingo tw'amaraso tw'umweru twitwa monocytes.
• Leukemia ikabije ya megakaryocytic (AMLK): Iyi ni kanseri y'uturemangingo dukora uturemangingo dutukura tw'amaraso cyangwa uduce duto tw'amaraso.
• Leukemia itera kanseri y’amaraso (APL): Muri ibi, ubwoko bw’uturemangingo tw’amaraso tw’umweru tudakuze twitwa promyelocytes ntibukura neza maze bugahinduka uturemangingo twa kanseri.

AML ikunze kugaragara gute?

Mu by’ukuri indwara ya AML ni indwara idakunze kugaragara. Ugereranyije, abantu bakuru bagera kuri 4 kuri 100.000 barwara iyi ndwara buri mwaka. Nanone, bivugwa ko abana bagera ku 1.160 bafatwa na AML buri mwaka.

Ni ibihe bimenyetso bya AML?

Mu ntangiriro, ibimenyetso bya AML bishobora kumera nk'aho ufite ibicurane cyangwa grippe umaze iminsi mike utameze neza. Ariko AML ni kanseri ikomeye cyane. Ibyo bivuze ko,Uzatangira kubona ibimenyetso bishya kandi bigaragara cyane. Nyuma, ushobora kubona ibimenyetso nk'ibi:

• Kumva uhora umeze nk'uzuzuzuzu.
• Ibintu nko gucika intege byoroshye, kuva amaraso kenshi mu mazuru, no kuva amaraso mu ishinya iyo woza amenyo.
• Kumva ufite umunaniro ukabije.
• Kumva ukonje.
• Umuriro.
• Kubira ibyuya nijoro.
• Kwandura indwara kenshi bibaho, cyangwa indwara zibaho zigafata igihe kirekire kugira ngo zikire.
• Kuribwa umutwe.
• Ibiryo nta buryohe bwabyo.
• Kuba unanutse nta mpamvu.
• Uruhu rwerurutse.
• Kugorwa no guhumeka (dyspnea).
• Utunyangingo tw'imitsi tubyimbye.
• Kumva ufite intege nke.
• Kubabara mu magufwa, mu mugongo, cyangwa mu gifu.
• Uduheri duto dutukura ku ruhu (petechiae).
• Ibikomere bifata igihe kugira ngo bikire.

Ni izihe mpamvu zitera AML?

Impuguke ntiziramenya neza icyatera AML. Ariko bazi ko iyo ndwara ibaho iyo gene cyangwa chromosomes zimwe na zimwe mu mibiri yacu zihindutse (mutate), bigatuma uturemangingo tw’amaraso tudasanzwe dukora. Izi mpinduka mu ngirabuzimafatizo zishobora kuba zirimo:

• Hari ikintu cyagize ingaruka kuri ADN yawe mu buzima bwawe.
• Niba ufite indwara y’uturemangingo ihererekanywa mu bisekuruza kandi ikongera ibyago byo kurwara AML.
• Bitewe n'impinduka muri zimwe mu ngirabuzimafatizo mu ntanga cyangwa amagi y'ababyeyi bawe.

Ni gute impinduka mu ngirabuzimafatizo zitera AML?

Kugira ngo wumve uburyo izi mpinduka mu ngirabuzimafatizo zishobora gutera AML, ni byiza kumenya bike ku igufwa ryawe n'uturemangingo tw'amaraso. Igufwa ryawe ni uturemangingo tworoshye kandi dufite umusemburo turi hagati mu magufwa yawe menshi. Rigizwe na:

• Uturemangingo tw’amaraso turaremwa. Utwo ni uturemangingo nyuma tuza kuba uturemangingo dutukura dutwara umwuka wa ogisijeni, uturemangingo tw’amaraso twera turinda kwandura, hamwe n’udupira dufasha amaraso kubumba.

Ubusanzwe, umwobo w'amagufwa yawe ukora nk'umurongo utanga umusaruro mwiza, ugakora ingano ikwiye y'uturemangingo tw'amaraso na plaquettes ku mubiri wawe. Ariko ku muntu urwaye AML, umwobo w'amagufwa utangira gukora uturemangingo tudasanzwe twa myeloid twitwa myeloid blasts cyangwa myeloblasts.

Izi selile za myeloid blast ntizikora nk'uturemangingo dusanzwe tw'amaraso. Selile zisanzwe zibona amabwiriza aturutse ku ngirabuzimafatizo zazo yerekeye igihe n'umuvuduko zigomba kwigabanyamo ibice no gukura. Iyo selile zishaje, zirapfa kugira ngo haboneke uturemangingo dushya mu musokoro w'amagufwa. Ariko selile za myeloid blast ntizikurikiza aya mabwiriza. Ziratandukana mu buryo butunguranye kandi ntizipfa. Uko selile za myeloid blast zikomeza kuzuza umwokoro w'amagufwa, nta mwanya w'uturemangingo tw'amaraso tuzima. Kubera ko nta mwanya, umwokoro w'amagufwa uhagarara gukora uturemangingo tw'amaraso tuzima. Iyo uturemangingo dushya tw'amaraso tuzima, umubiri ntubona ibintu ukeneye kugira ngo ukore neza.

Byongeye kandi, uko utwo turemangingo tw’imitsi dukomeza kwigabanyamo ibice, tuva mu musokoro w’amagufwa tujya mu maraso. Iyo tugeze mu maraso, utwo turemangingo tw’imitsi tugenda tujya mu bindi bice by’umubiri, harimo n’imitsi yo hagati, ubwonko, n’umugongo.

Ni ibihe bintu bishobora gutera AML?

Nubwo impuguke zitazi neza impamvu zitera impinduka mu miterere y’uturemangingo zitera AML, bazi ibintu bimwe na bimwe (ibintu bishobora gutera ibyago) byongera ibyago byo kurwara iyi ndwara. (Iyo dutekereje ku bintu bishobora gutera ibyago, ni ngombwa kwibuka ko kugira ikintu gishobora gutera ibyago bidasobanura ko uzarwara iyi ndwara. ) Ibintu bishobora gutera AML birimo:

• Imyaka: Hafi kimwe cya kabiri cy'abantu barwara AML baba bafite imyaka 65 cyangwa irenga iyo bayisuzumye. Ariko, nk'uko byavuzwe mbere, AML ikunze kugaragara cyane mu bantu bakuru, ariko ishobora no kugaragara no mu bana.
• Kunywa itabi: Ibi birimo guhumeka umwotsi w'itabi.
• Uburyo bwo kuvura kanseri: Ibintu nka chimiotherapie na radiation therapy.
• Guhura n'ibintu bimwe na bimwe bitera kanseri mu mubiri igihe kirekire: Ingero zirimo ibintu nka benzene na formaldehyde.
• Guhura n'imirasire myinshi ituruka ku mpanuka y'ingufu za kirimbuzi cyangwa igisasu cya atomiki.
• Zimwe mu ndwara z’uturemangingo twavukanye.
• Izindi ndwara z'umusemburo w'amagufwa.

Ni izihe ndwara z’uturemangingo zongera ibyago byo kurwara AML?

Abashakashatsi bavumbuye ko hari impinduka zimwe na zimwe mu ngirabuzimafatizo z’umubiri umuntu avukana zongerera ibyago byo kurwara AML. Zimwe muri zo zirimo:

• Indwara ya Down
• Ataxia telangiectasia
• Indwara ya Li-Fraumeni
• Indwara ya Klinefelter
• Kubura amaraso mu mubiri (Fanconi anemia)
• Indwara ya Wiskott-Aldrich - Ibi bigira ingaruka ku ikorwa ry'udukoko twa platelet.
• Indwara y'urumuri
• Indwara ya Family Platelet Disorder - Iyi nayo ni indwara iterwa n'udukoko duto.

Ni izihe ndwara z'umusemburo w'amagufwa zongera ibyago byo kurwara AML?

Bamwe mu bantu bafite myeloproliferative neoplasms, cyangwa indwara za myeloproliferative, bashobora kurwara kanseri y'imitsi ikabije. (Myelo bivuga umwongo w'amagufwa. Kwiyongera bivuze gukura cyane.) Abantu bafite indwara zikurikira nabo bafite ibyago byinshi byo kurwara AML:

• Polycythemia vera
• Myelofibrose
• Thrombocytosis
• Indwara ya Myelodysplastic
• Kubura amaraso mu mubiri (Aplastic anemia)

Ni izihe ngorane zishobora guterwa na AML?

Mu ntangiriro zayo, kanseri y’amaraso ya myeloid ifata umubare w’uturemangingo tw’amaraso dutukura, uturemangingo tw’amaraso twera, n’uturemangingo tw’amaraso mu mubiri wawe. Niba udafite uturemangingo tw’amaraso na platelets bihagije, ushobora guhura n’indwara nk’izi:

• Anemia - bivuze kubura amaraso.
• Thrombocytopenia - Ibi bivuze kubura kwa platelets.
• Pancytopenia - Ibi bivuze kugabanuka kw'ubwoko bwose bw'uturemangingo tw'amaraso na platelets.

Indwara ya AML ipimwa ite? (Isuzuma)

Abaganga bakoresha ibizamini byinshi kugira ngo bamenye AML, harimo n'ibizamini bya genetiki kugira ngo bamenye ubwoko nyabwo bwa AML. Intambwe ya mbere akenshi ni isuzuma ry'umubiri. Ibi birimo gusuzuma ko nta bikomere, kuva amaraso, n'ubwandu. Banasuzuma ko nta kubyimba mu ngingo nk'umwijima, urwagashya, n'uturemangingo tw'amaraso.

Ni ibihe bipimo bikoreshwa mu gusuzuma AML?

Ushobora gukenera gukora kimwe cyangwa byinshi muri ibi bizamini:

• Umubare w'amaraso yuzuye (CBC)
• Gupima amaraso mu buryo bworoshye - Ibi bikubiyemo gufata amaraso no kuyareba muri mikorosikopi.
• Bisipo y'umusemburo w'amagufwa - Muri ibi, hafatwa icyitegererezo gito cy'umusemburo w'amagufwa hanyuma kigasuzumwa.
• Gukanda uruti rw'umugongo - Ibi rimwe na rimwe bikorwa kugira ngo harebwe uturemangingo twa kanseri mu mazi akikije uruti rw'umugongo.

Ni ibihe bipimo by'uturemangingo bikoreshwa mu gusuzuma AML?

Abaganga b'indwara bakora ibizamini bya genetiki kugira ngo bamenye ubwoko nyabwo bwa AML. Bashakisha impinduka (mutations) muri chromosomes cyangwa gene zimwe na zimwe. Iyo ubwoko bwa AML bumenyekanye, biroroha abaganga guhitamo uburyo bwo kuvura bushobora kuvura AML. Bimwe mu bizamini byihariye bikorwa muri iyo ntego ni ibi bikurikira:

• Ubuvuzi bw'umubiri: Muri ibi, uturemangingo turandurwa kandi tugasuzumwa hifashishijwe mikorosikopi. Uburyo bwo gusiga irangi buratandukanye bitewe n'imiti iri mu turemangingo.
• Isesengura ry'imiterere y'amazi.
• Ikizamini cya Karyotype.
• Guhuza imiterere y'amafi (Fluorescence-in-situ-hybridization): Ibi bishobora kumenya impinduka muri chromosomes.

Ni ubuhe buryo bwo kuvura AML?

Uburyo bwo kuvura burimo imiti igabanya ubukana bw’indwara ya kanseri (chimiotherapie), uburyo bwo kuvura hifashishijwe uburyo bwa “monoclonal antibody therapy”, cyangwa “allogeneic stem cells”. Uburyo bumwe bwo kuvura burahari ku bantu bakuru no ku bana. Intego nyamukuru yo kuvura ni ukugera ku buremere bwuzuye bwa AML.Muri AML, 'gukira burundu' bivuze ko umubare w'amaraso yawe ari nk'uko bisanzwe mu bipimo. Bivuze kandi ko abaganga badashobora kubona uturemangingo twa kanseri iyo barebye icyitegererezo cy'umusemburo wawe bakoresheje mikorosikopi.

Chimiotherapie kuri AML

Hari ibyiciro bitatu by'ingenzi bya chimiotherapie kuri AML - induction, consolidation, na maintenance.

Uburyo bwo kuvura indwara yo kugabanya ububabare

Iyi ni intambwe ya mbere yo gukuraho AML burundu. Ubusanzwe ubuvuzi bumara iminsi mike. Hari abantu bashobora gukenera inshuro ebyiri cyangwa zirenga z'ubu buryo bw'ibanze bwo kuvura kugira ngo bakureho AML burundu. Abaganga bashobora gukoresha imiti ikurikira ya chimiotherapie kuri ubu buryo bw'ibanze:

• Cytarabine (Cytosar-U®)
• Daunorubicin (Cerubidine®)
• Idarubicin (Idamycin®)
• Azacitidine (Vidaza®)
• Decitabine (Dacogen®)
• Glasdegib (Daurismo®)
• Venetoclax (Venclexta®, Venclyxto®)

Nk’uko abahanga babivuga, ubu buryo bw’ibanze bwo kuvura:

• Abana n'urubyiruko barenga 60% barakira.
• Abantu bakuru bafite imyaka 60 no munsi yayo bagera kuri 75% barakira.
• Abantu barengeje imyaka 60 bagera kuri 50% barakira.

Uburyo bwo kuvura hifashishijwe uburyo bwo guhuza

Uburyo bwo kuvura kanseri bukoreshwa mu kwica uturemangingo twa kanseri dusigaye. Ibi bigabanya ibyago byo kugaruka kwa kanseri (recurrent). Abantu benshi bahabwa umuti wa cytarabine (Ara-C) cyangwa HiDAC ufite dose nyinshi mu gihe cy'iminsi itanu buri kwezi mu gihe cy'amezi atatu kugeza kuri ane.

Ubuvuzi bwo kubungabunga

Akenshi, AML irakira hakoreshejwe uburyo bwo kuvura indwara zifatana. Ariko, mu bihe bimwe na bimwe, abaganga bashobora gusaba ko umuntu akomeza gukoresha imiti ya chimiotherapie ku rugero ruto. Uburyo bwo kuvura indwara zishobora gukomeza mu gihe cy'amezi cyangwa imyaka. Imiti ya chimiotherapie ikoreshwa mu kuvura indwara ishobora kuba ikubiyemo:

• Azacitidine (Vidaza®)
• Decitabine (Dacogen®)
• Midostaurini (Rydapt®)

Ubuvuzi bwibasiwe

Nk'uko izina ribigaragaza, ubu buryo bwo kuvura bwibanda ku mpinduka zihariye mu turemangingo twa kanseri. Mu kwibanda kuri izi mpinduka, uturemangingo twa kanseri duhagarika gukura. Uburyo bwo kuvura uturemangingo tw’umubiri (antibody therapy) nabwo ni ubwoko bw’uburyo bwo kuvura bwibanda ku buryo bugamije. Abaganga bashobora gukoresha uburyo bwo kuvura bwagenewe kuvura AML itarakira imiti cyangwa yagarutse:

• Abaganga bashobora gukoresha imiti ya chimiotherapie Midostaurin (Rydapt®) cyangwa Gilteritinib (Xospata®) kugira ngo bavure abarwayi ba AML bafite ihinduka rya gene ya FTL3. Iri hinduka riboneka ku bantu 25% kugeza kuri 30% bafite AML.
• Enasidenib (IDHIFA®) cyangwa Ivosidenib (Tibsovo®) ishobora gukoreshwa mu kuvura abantu bafite AML bitewe n'impinduka mu ngirabuzimafatizo X.

Gutera uturemangingo tw’umugongo twa allogene

Gutera uturemangingo tw’inyuma tw’umubiri hakoreshejwe uturemangingo tw’inyuma tw’umubiri dukomoka ku muntu ufitanye isano cyangwa udafite aho ahuriye na two. Abaganga bashobora kubona utwo turemangingo tw’inyuma mu musokoro w’amagufwa, mu maraso yo ku ruhande, cyangwa mu maraso y’inyuma y’umubiri (amaraso yakusanyijwe mu musokoro w’inyuma nyuma yo kuvuka).

Ingaruka cyangwa ingaruka mbi zo kuvurwa

Uburyo bwo kuvura kanseri hafi ya bwose bugira ingaruka mbi. Muri AML, gutera uturemangingo fatizo bigira ingaruka mbi zikomeye cyane. Chimiotherapie ishobora gutera indwara yitwa myelosuppression, bivuze ko umubiri wawe utakaza umubare usanzwe w'uturemangingo tw'amaraso na platelets. Ingaruka mbi z'ubuvuzi bugamije ziratandukanye bitewe n'umuti ukoreshwa.

Gusobanukirwa ingaruka mbi ni ingenzi kugira ngo umenye uburyo kuvura kanseri bigira ingaruka ku buzima bwawe bwa buri munsi. Muganga wawe ni we muntu mwiza wo kumenya ingaruka mbi zikomoka ku buvuzi bwawe. Hari abantu bashobora kungukirwa no kuvurwa mu buryo bwo kugabanya ububabare kugira ngo bagufashe mu kuvura ingaruka mbi.

Ese AML ishobora gukira burundu?

Kuri ubu, gutera uturemangingo tw’inyuma twa allogeneic ni bwo buryo bwonyine bwo gukiza burundu kanseri y’imitsi ikabije. Bitewe n’uburwayi bwawe, muganga wawe ashobora kukugira inama yo gutera uturemangingo tw’inyuma nk’ubuvuzi bwawe bwa mbere bwa AML. Cyangwa, niba AML yawe igarutse mu mezi 12, ubu buryo bushobora kuba ari bwo butangwa. Ikibabaje ni uko atari buri wese wemerewe guterwa uturemangingo tw’inyuma.

Ni iki gipimo cy'uko AML ibaho?

Iyo tuvuze ku birebana n'uko kanseri y'imitsi ishobora kugaragara, hari ibintu bibiri: Kimwe ni uko indwara ya kanseri y'imitsi igabanuka burundu. Ikindi ni uko indwara yo kugaruka, ari na bwo AML yongera kugaragara.

• Muri rusange, bivugwa ko hagati ya 50% na 80% by'abantu barwaye kanseri y'imitsi itera kanseri bazakira neza nyuma yo kuvurwa. Abana n'abantu bari munsi y'imyaka 60 bafite amahirwe menshi yo gukira neza. Uku gukira gushobora kumara amezi cyangwa imyaka.
• Abantu bagera kuri 50% bakize burundu bazongera kurwara AML. Ibi nibibaho, abaganga bashobora gusaba ko bongera guhabwa imiti cyangwa se bagaterwa uturemangingo tw’umubiri. Bashobora kandi gutanga inama yo kwitabira igerageza rya muganga.

Niba wowe cyangwa umwana wawe afite AML, baza muganga wawe icyo ushobora kwitega.

Ni iki gipimo cyo kubaho cy'abarwayi ba AML?

Leukemia y'imitsi ikabije ni indwara igoye. Kubera ko hari ubwoko bwinshi bwa AML, biragoye gutanga igitekerezo nyacyo cy'uko indwara izagenda.

Urugero, igipimo cy’imyaka itanu yo kubaho ku bana bari munsi y’imyaka 15 ni 67%. Ariko hari ubushakashatsi bugaragaza ko igipimo cy’imyaka itanu yo kubaho ku bana bafite ubwoko bwa APL kiri hejuru ya 80%. Imyaka nayo igira uruhare. Ugereranyije, 30% by’abantu bakuru bafite AML bararokoka nyuma y’imyaka itanu barwaye. Wibuke ko AML ikunze kugaragara ku bantu bafite imyaka 60 kuzamura, kandi bashobora no kugira izindi ngorane z’ubuzima.

Ni ngombwa kwibuka ko ibi bipimo byo kurokoka bigaragaza ubunararibonye bw'amatsinda manini y'abantu bafite AML. Aya makuru arimo ibipimo byo kurokoka kuva mu 2012 kugeza 2018, kandi ubu hari uburyo bushya kandi bwiza bwo kuvura AML.

Hari ibintu byinshi bigira ingaruka ku gihe uzamara urwaye kanseri y’imitsi ikabije. Ibi bivuze ko abaganga bawe, bazi amateka y’ubuzima bwawe n’ubuzima bwawe muri rusange, ari bo bantu beza bo kumenya kuri ibi.

Ese AML ishobora kwirindwa?

Oya, kanseri y'imitsi ishobora kwirindwa. Nubwo abahanga bazi ko AML iterwa n'impinduka mu ngirabuzimafatizo, ntibazi icyayitera. Ariko bazi ibintu bishobora gutera AML. Dore bimwe mu bintu bishobora gutuma umuntu arwara:

• Kunywa itabi: Ibi birimo itabi ry'abantu banywa itabi. Niba unywa itabi, gerageza kurireka. Niba ubana cyangwa ukorana n'umuntu unywa itabi, gerageza kugabanya igihe umarana na we iyo arimo kunywa itabi.
• Guhura n'ibintu bimwe na bimwe bitera kanseri igihe kirekire: cyane cyane benzene na formaldehyde. Niba ukorana n'ibi bintu bitera kanseri, fata ingamba zose z'umutekano, nko kwambara imyenda yo kwirinda.

Niyitaho nte? (Kwiyitaho)

Kubana na kanseri ishobora kugaruka ntabwo byoroshye. Kwinjira muri gahunda zo kurokoka kanseri ni bumwe mu buryo ushobora kwiyitaho. Ushobora kudashobora guhagarika kanseri y'imitsi ikabije kugaruka. Ariko ushobora gufata ingamba zo kugumana ubuzima bwiza uko bishoboka kose, uko byagenda kose. Dore bimwe mu bitekerezo:

• Kuvura kanseri y'imitsi ishobora kugira ingaruka ku mirire yawe.Ugomba kurya neza kugira ngo ukomeze kugira imbaraga. Niba ufite ikibazo cyo kurya, vugana n'inzobere mu by'imirire.
• Ingaruka mbi zo kuvurwa na AML zishobora kugorana kuzikemura. Niba bikenewe, vugana na muganga wawe ku bijyanye no kwita ku ndwara zigabanya ububabare.
• Kanseri ni indwara ihangayikisha cyane. Imyitozo ngororamubiri ishobora kugufasha gucunga imihangayiko. Ariko vugana na muganga wawe mbere yo gutangira gahunda nshya kandi igoye yo gukora imyitozo ngororamubiri.
• Kanseri ishobora gutuma wumva ufite irungu. AML ni indwara idakunze kugaragara. Ushobora kugira ubwoba bwo kuvuga ku kibazo cyawe. Niba ari uko bimeze, tekereza kujya mu itsinda ry’abaterankunga.
• Leukemia y'imitsi ishobora gutuma wumva unaniwe cyane. Uburyo bwo kuvura bushobora kugutwara imbaraga. Wibuke gusinzira bihagije uko ukeneye.

Ni ryari ngomba kujya kwa muganga?

Uzajya ubonana na muganga wawe buri gihe mu gihe cyose cyo gukira, cyane cyane niba uri guhabwa imiti igufasha kwitabwaho. Muganga wawe azakubwira ibimenyetso bishobora kuba ibimenyetso by'uko AML yawe igarutse. Ibi bizagufasha kumenya igihe cyo kubahamagara kugira ngo bagufashe kuvurwa bundi bushya cyangwa ubundi buryo.

Ni ibihe bibazo ngomba kubaza muganga wanjye?

Niba ufite AML, ushobora kwibaza ibi bibazo:

• Ni ubuhe bwoko bwa AML mfite?
• Ni ubuhe buryo bwo kuvurwa?
• Ni izihe ngaruka mbi n'ingaruka mbi zo kuvurwa?
• Ni gute nakwitwara mu guhangana n'ingaruka mbi zo kuvurwa?
• Ni ubuhe buvuzi nkeneye nyuma yo kuvurwa?
• Ese nkwiye kwitondera ibimenyetso by'ingorane?
• Ese hari igeragezwa ry'ubuvuzi nkwiye gusuzuma?

Amaherezo, ibintu byo kwibuka

Leukemia ikabije ya Myeloid (AML) ni kanseri idakunze kugaragara ifata umwongo w'amagufwa no mu maraso. AML ikunze kwibasira abantu barengeje imyaka 65, ariko ishobora no kwibasira abana n'urubyiruko. Kubera uburyo bushya bwo kuvura, abantu benshi ubu babana na AML nyuma yo kuvurwa. Nubwo kanseri ishobora kugaruka, abashakashatsi mu by'ubuvuzi bakomeje gukora ubushakashatsi ku buryo bwo kuvura AML igaruka.

Niba wowe cyangwa umwana wawe murwaye kanseri y'imitsi ikabije, mushobora kumva mumeze nk'aho mwajugunywe mu butaka bukomeye mu nyanja itazwi neza. Mushobora kwibaza niba kuvurwa bizabafasha. Niba ari uko bimeze, mushobora guhangayikishwa n'igihe ubwo buvuzi buzamara. Abaganga banyu basobanukiwe uko mwiyumva. Bazabana namwe mu gihe muhanganye n'ibibazo bya AML. Komeza rero ukomere kandi ntutindiganye kubona ubufasha mukeneye.

Leukemia y'imitsi ikabije , AML, kanseri y'amaraso, umworera w'amagufwa, ibimenyetso, imiti ivura indwara ya kanseri, gutera uturemangingo tw'umubiri